-
2024 CASH | Professor ChunYan Ji : Significant Advances in Leukemia Treatment, Aiming to Achieve Treatment-Free Remission for More Patients
“Oncology Frontier – Hematology Frontier“: As the chairman of the “Leukemia” session, could you discuss the significant research advancements in the diagnosis and treatment of leukemia in recent years, especially in…
-
Dr. Nicholas Short: The Latest Therapeutic Advances in Acute Lymphoblastic Leukemia
Abstract: Dr. Nicholas Short delves into the forefront of advancements in the treatment of Acute Lymphoblastic Leukemia (ALL) at the EHA Congress 2023. He discusses the evolution of therapeutic strategies, particularly in B cell ALL, where various agents like blinatumomab, inotuzumab ozogamicin, and CD19 CAR T cell products have demonstrated notable efficacy. Notably, the focus…
-
Dr. Huang Huiqiang: Immune Therapy Era is Imminent for Extranodal NK/T Cell Lymphoma
Extranodal NK/T cell lymphoma (ENKTCL), nasal type, is a rare subtype prevalent in Asian populations and associated with the Epstein-Barr virus (EBV). Currently, patients’ prognosis remains poor, especially for relapsed/refractory (R/R) cases. From June 8th to 11th, 2023, the 28th European Hematology Association (EHA) Annual Congress was held in Frankfurt, Germany. A selected oral presentation…
-
Dr. Hou Ming: BTK Inhibitor Ibrutinib Offer Limitless Prospects for ITP Treatment
Editor’s Note: From June 8th to 11th, 2023, the 28th European Hematology Association (EHA) Congress was held in Frankfurt, Germany. During this conference, Dr. Hou Ming’s team at Qilu Hospital, Shandong University, China, presented the research findings on the use of the BTK inhibitor ibrutinib for primary immune thrombocytopenia (ITP) (abstract S299). To gain deeper…
-
Dr. Amir Fathi: The Latest Advances in Targeted Therapy for Acute Myeloid Leukemia
Abstract: In this interview, Dr. Amir Fathi provides insights into the impact of NPM1 mutations on the prognosis of acute myeloid leukemia (AML) patients, emphasizing the evolving nuances based on…
-
Dr. Ma Jun: Immunotherapy Progress and Future Trends in Acute Lymphoblastic Leukemia
Editor’s Note: The 28th European Hematology Association (EHA) Congress, held from June 8th to June 11th, 2023, in Frankfurt, Germany, presented a combination of online and offline formats. As the…
-
Dr. WeipingCai: Long-Acting Antiretroviral Drugs Usher in a New Chapter in AIDS Care
Infectious Disease Frontier specially invited Dr. Weiping Cai from the Eighth Affiliated Hospital of Guangzhou Medical University, China, to provide insightful comments on this hot research area.
Connecting Medical Expertise through Media
